NRCM
NKGNW

Northern Right Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Northern Right Capital Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30,000
Closed -$35K – 45
2021
Q4 		$35K Hold
30,000
– – 0.01% 76
2021
Q3 		$35K Buy
+30,000
New +$37.5K 0.01% 84

Other funds holding NKGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.44% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return

Northern Right Capital Management's NKGNW Position: Q1 2022 in Review

Northern Right Capital Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2022, closing a stake of 30,000 shares — an estimated $35K sold.

Northern Right Capital Management first reported a position in NKGNW in Q3 2021 and held it in 2 quarters. The position peaked at $35K in Q4 2021. 31 funds tracked by Wall St. Rank hold NKGNW as of Q1 2022.

  • Northern Right Capital Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2022 after selling out during the quarter.
  • Northern Right Capital Management sold 30,000 NKGen Biotech, Inc. Warrants shares in Q1 2022, an estimated $35K.
  • Northern Right Capital Management first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 2 quarters.
  • Northern Right Capital Management's NKGen Biotech, Inc. Warrants position peaked at $35K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2022.

Based on Northern Right Capital Management's 13F filing for Q1 2022, filed 16 May 2022.